Activated NOTCH2 is overexpressed in hepatoblastomas: An immunohistochemical study

Pediatric and Developmental Pathology

Volumn 14, Issue 5, 2011, Pages 378-383

  Litten, Jason B ^a   Chen, Tina T L ^b   Schultz, Roger ^a   Herman, Karl ^c   Comstock, Jessica ^c   Schiffman, Joshua ^c   Tomlinson, Gail E ^b,d   Rakheja, Dinesh ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Hepatoblastoma; Immunohistochemistry; Liver; NOTCH; NOTCH2

Indexed keywords

JAGGED1; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; FEMALE; FETUS; GENE LOCUS; GENE MAPPING; GENE OVEREXPRESSION; HEPATOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LIVER CELL; LIVER DEVELOPMENT; LIVER SINUSOID; MALE; NEWBORN; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL;

CALCIUM-BINDING PROTEINS; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; CYTOPLASM; FEMALE; HEPATOBLASTOMA; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; RECEPTOR, NOTCH2; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84855399437     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/10-09-0900-OA.1     Document Type: Article

References (22)

1. Zaret KS. Liver specification and early morphogenesis. Mech Dev 2000;92:83-88. (Pubitemid 30125963)
2. Schneider NR, Cooley LD, Finegold MJ, Douglass EC, Tomlinson GE. The first recurring chromosome translocation in hepatoblastoma: der(4)t(1;4) (q12;q34). Genes Chromosomes Cancer 1997;19: 291-294. (Pubitemid 27330242)
3. Tomlinson GE, Douglass EC, Pollock BH, Finegold MJ, Schneider NR. Cytogenetic evaluation of a large series of hepatoblastomas: numerical abnormalities with recurring aberrations involving 1q12-q21. Genes Chromosomes Cancer 2005;44:177-184. (Pubitemid 41306646)
4. Loomes KM, Taichman DB, Glover CL, et al. Characterization of notch receptor expression in the developing mammalian heart and liver. Am J Med Genet 2002;112:181-189. (Pubitemid 35332184)
5. Kapur P, Rakheja D. Immunohistochemical expression of NCAM in Wilms tumors, nephrogenic rests, and fetal and postnatal renal cortices. Pediatr Dev Pathol 2010;14:16-19.
6. Litten JB, Tomlinson GE. Liver tumors in children. Oncologist 2008;13:812-820.
7. Herzog CE, Andrassy RJ, Eftekhari F. Childhood cancers: hepatoblastoma. Oncologist 2000;5:445-453.
8. Wang LL, Filippi RZ, Zurakowski D, et al. Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study. Am J Surg Pathol 2010;34:287-299.
9. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999;284:770-776. (Pubitemid 29291335)
10. Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004;306:269-271. (Pubitemid 39336870)
11. Stylianou S, Clarke RB, Brennan K. Aberrant activation of notch signaling in human breast cancer. Cancer Res 2006;66:1517-1525. (Pubitemid 43259933)
12. Zagouras P, Stifani S, Blaumueller CM, Carcangiu ML, Artavanis- Tsakonas S. Alterations in notch signaling in neoplastic lesions of the human cervix. Proc Natl Acad Sci U S A 1995;92:6414-6418.
13. Zhang P, Yang Y, Zweidler-McKay PA, Hughes DP. Critical role of notch signaling in osteosarcoma invasion and metastasis. Clin Cancer Res 2008;14:2962-2969.
14. Konishi J, Kawaguchi KS, Vo H, et al. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Cancer Res 2007;67:8051-8057. (Pubitemid 47395139)
15. Lopez-Terrada D, Gunaratne PH, Adesina AM, et al. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. Hum Pathol 2009;40:783-794.
16. Chen TT, Rakheja D, Hung JY, et al. Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor. Pediatr Blood Cancer 2009;53:1040-1047.
17. Dufraine J, Funahashi Y, Kitajewski J. Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene 2008;27: 5132-5137.
18. Kume T. Specification of arterial, venous, and lymphatic endothelial cells during embryonic development. Histol Histopathol 2010;25: 637-646.
19. Roca C, Adams RH. Regulation of vascular morphogenesis by notch signaling. Genes Dev 2007;21:2511-2524. (Pubitemid 47607663)
20. Funahashi Y, Hernandez SL, Das I, et al. A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis. Cancer Res 2008;68:4727-4735.
21. Lewandowska E, Szpak GM, Wierzba-Bobrowicz T, et al. Capillary vessel wall in CADASIL angiopathy. Folia Neuropathol 2010;48: 104-115.
22. Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. Cadasil. Lancet Neurol 2009;8:643-653.